HIV and HCV treatment for people with coinfection
In 2017, treatment guidelines recommend HIV treatment for all HIV positive people. This include people with HCV coinfection.
Guidelines also recommend HCV treatment in all people with HIV coinfection.
ART in people with coinfection
The main concerns when choosing HIV treatment for someone with HCV are:
- Avoiding liver toxicity and damage from HIV drugs, and
- Awareness of drug interactions with HCV treatment.
Luckily, only a few HIV drugs increase the risk of liver complications in people with HCV. These are now either rarely used (d4T, ddI, tipranavir etc) or easy to avoid (nevirapine).
As DAAs only require a short course of treatment, any potential drug interactions are easy to avoid by changing ART during HCV treatment.
Last updated: 17 August 2017.